Literature DB >> 4430891

Host genetic control of recovery from Friend leukemia virus-induced splenomegaly: mapping of a gene within the major histocompatability complex.

B Chesebro, K Wehrly, J Stimpfling.   

Abstract

The influence of the major mouse histocompatibility gene complex (H-2) on the response of mice to Friend leukemia virus was studied in F(1) congenic mice differing only at genes within the H-2 complex. F(1) mice which were H-2(b/b) had a high incidence of recovery from splenomegaly compared to H-2(b/d) or H-2(b/a) mice. In mice with recombinations within the H-2 complex a gene (designated RFV-1), responsible for the Friend virus recovery effect, was found to map near or within the D region of serologically detectable transplantation antigens. Because the incidence of recovery was much higher in F(1)H-2(b/b) mice than in parental H-2(b/b) mice, other non-H-2 host genetic factors also appear to be important to expression of recovery in H-2(b/b) F(1) mice. The mechanisms of action of these genes remain unknown.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4430891      PMCID: PMC2139745          DOI: 10.1084/jem.140.6.1457

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

1.  Host-induced changes in infectivity of Friend spleen focus-forming virus.

Authors:  R A Steeves; R J Eckner
Journal:  J Natl Cancer Inst       Date:  1970-03       Impact factor: 13.506

2.  ASSAY FOR FRIEND LEUKEMIA VIRUS: RAPID QUANTITATIVE METHOD BASED ON ENUMERATION OF MACROSCOPIC SPLEEN FOCI IN MICE.

Authors:  A A AXELRAD; R A STEEVES
Journal:  Virology       Date:  1964-11       Impact factor: 3.616

3.  Isolation and characterization of a lymphatic leukemia virus in the Friend virus complex.

Authors:  R A Steeves; R J Eckner; M Bennett; E A Mirand; P J Trudel
Journal:  J Natl Cancer Inst       Date:  1971-06       Impact factor: 13.506

4.  The histocompatability-2 locus and susceptibility to bittner virus borne by red blood cells in mice.

Authors:  S Nandi
Journal:  Proc Natl Acad Sci U S A       Date:  1967-08       Impact factor: 11.205

5.  The influence of age on chronic remittent Friend disease.

Authors:  P J Dawson; A H Fieldsteel
Journal:  Cancer Res       Date:  1971-07       Impact factor: 12.701

6.  The role of genetics in Gross virus leukemogenesis.

Authors:  F Lilly
Journal:  Bibl Haematol       Date:  1970

7.  Evidence supporting a two-gene model for the H-2 histocompatibility system of the mouse.

Authors:  J Klein; D C Shreffler
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

8.  Relationship between Friend virus and an associated lymphatic leukaemia virus.

Authors:  P J Dawson; R B Tacke; A H Fieldsteel
Journal:  Br J Cancer       Date:  1968-09       Impact factor: 7.640

9.  A major genetic locus affecting resistance to infection with murine leukemia viruses. II. Apparent identity to a major locus described for resistance to friend murine leukemia virus.

Authors:  T Pincus; W P Rowe; F Lilly
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

10.  The effect of histocompatibility-2 type on response to friend leukemia virus in mice.

Authors:  F Lilly
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

View more
  75 in total

1.  Kinetics of the development of protective immunity in mice vaccinated with a live attenuated retrovirus.

Authors:  U Dittmer; B Race; K J Hasenkrug
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

Review 2.  Individuality in disease and therapy.

Authors:  B Cinader
Journal:  Can Med Assoc J       Date:  1975-07-12       Impact factor: 8.262

3.  Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection.

Authors:  Wibke Bayer; Matthias Tenbusch; Ruth Lietz; Lena Johrden; Simone Schimmer; Klaus Uberla; Ulf Dittmer; Oliver Wildner
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

4.  Role of natural killer cells in resistance against friend retrovirus-induced leukemia.

Authors:  N Iwanami; A Niwa; Y Yasutomi; N Tabata; M Miyazawa
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness.

Authors:  K J Hasenkrug; D M Brooks; B Chesebro
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

6.  Contrasting effects from a single major histocompatibility complex class II molecule (H-2E) in recovery from Friend virus leukemia.

Authors:  L L Perry; M Miyazawa; K Hasenkrug; K Wehrly; C S David; B Chesebro
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

7.  Comparative Evaluation of the Vaccine Efficacies of Three Adenovirus-Based Vector Types in the Friend Retrovirus Infection Model.

Authors:  Camilla Patrizia Hrycak; Sonja Windmann; Wibke Bayer
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

8.  Adoptive transfer of polyclonal and cloned cytolytic T lymphocytes (CTL) specific for mouse AIDS-associated tumors is effective in preserving CTL responses: a measure of protection against LP-BM5 retrovirus-induced immunodeficiency.

Authors:  W R Green; K A Green; K M Crassi
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

9.  Persistence of infectious Friend virus in spleens of mice after spontaneous recovery from virus-induced erythroleukemia.

Authors:  B Chesebro; M Bloom; K Wehrly; J Nishio
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

10.  Suppression of H-2b-associated resistance to Friend erythroleukemia virus by a class I gene from the H-2d major histocompatibility complex haplotype.

Authors:  D Polsky; F Lilly
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.